US Supreme Court questions legitimacy of case seeking to ban mifepristone

Janice Hopkins Tanne
DOI: https://doi.org/10.1136/bmj.q763
2024-03-28
BMJ
Abstract:US Supreme Court justices appeared sceptical when hearing oral arguments in a case seeking to ban mifepristone, questioning the legitimacy of the group that brought the case and largely ignoring the question of whether mifepristone should be banned.1Last year the Alliance for Hippocratic Medicine, which says it values the sanctity of life from fertilisation to natural death, sued the Food and Drug Administration (FDA) in a lower court, claiming that mifepristone, one of two drugs used in medication abortions, was dangerous to women and had been wrongly approved. The judge ordered FDA to take mifepristone off the market but the ruling was suspended and the case was appealed to the Supreme Court.2The case is important because medication abortions are now used in about two thirds of US abortions and because it challenges FDA authority and its scientific rulings.During the Supreme Court hearings on 26 March the nine justices focused their...
medicine, general & internal
What problem does this paper attempt to address?